Artificial Intelligence in Mammography Screening in Norway — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Artificial Intelligence in Mammography Screening in Norway — Stella

Recruiting

Back to Breast Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Norway

Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo

Key details

Sponsor

Norwegian Institute of Public Health

Collaborators

Helse Vest, Helse Midt-Norge

Enrollment target

~150,000 participants

Started

November 2024

Primary completion

November 2026

Age range

50 Years – 69 Years

Sex

Female only

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov